GB201711360D0 - Tissue scaffold - Google Patents

Tissue scaffold

Info

Publication number
GB201711360D0
GB201711360D0 GBGB1711360.6A GB201711360A GB201711360D0 GB 201711360 D0 GB201711360 D0 GB 201711360D0 GB 201711360 A GB201711360 A GB 201711360A GB 201711360 D0 GB201711360 D0 GB 201711360D0
Authority
GB
United Kingdom
Prior art keywords
tissue scaffold
scaffold
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1711360.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raft Enterprises Ltd
Original Assignee
Raft Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raft Enterprises Ltd filed Critical Raft Enterprises Ltd
Priority to GBGB1711360.6A priority Critical patent/GB201711360D0/en
Publication of GB201711360D0 publication Critical patent/GB201711360D0/en
Priority to CA3068926A priority patent/CA3068926A1/en
Priority to AU2018298970A priority patent/AU2018298970B2/en
Priority to ES18745693T priority patent/ES2948984T3/es
Priority to US16/630,638 priority patent/US11738112B2/en
Priority to EP18745693.4A priority patent/EP3651817B1/en
Priority to PCT/GB2018/052002 priority patent/WO2019012295A1/en
Priority to EP23169720.2A priority patent/EP4338764A3/en
Priority to JP2020501365A priority patent/JP2020526337A/ja
Priority to JP2023095521A priority patent/JP7693152B2/ja
Priority to US18/349,192 priority patent/US20240165299A1/en
Priority to AU2024220141A priority patent/AU2024220141A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
    • C12N2537/10—Cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laser Surgery Devices (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)
GBGB1711360.6A 2017-07-14 2017-07-14 Tissue scaffold Ceased GB201711360D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1711360.6A GB201711360D0 (en) 2017-07-14 2017-07-14 Tissue scaffold
JP2020501365A JP2020526337A (ja) 2017-07-14 2018-07-13 組織足場
US16/630,638 US11738112B2 (en) 2017-07-14 2018-07-13 Tissue scaffold
AU2018298970A AU2018298970B2 (en) 2017-07-14 2018-07-13 Tissue scaffold
ES18745693T ES2948984T3 (es) 2017-07-14 2018-07-13 Andamio tisular
CA3068926A CA3068926A1 (en) 2017-07-14 2018-07-13 Tissue scaffold
EP18745693.4A EP3651817B1 (en) 2017-07-14 2018-07-13 Tissue scaffold
PCT/GB2018/052002 WO2019012295A1 (en) 2017-07-14 2018-07-13 TISSUE SCAFFOLDING
EP23169720.2A EP4338764A3 (en) 2017-07-14 2018-07-13 Tissue scaffold
JP2023095521A JP7693152B2 (ja) 2017-07-14 2023-06-09 組織足場
US18/349,192 US20240165299A1 (en) 2017-07-14 2023-07-10 Tissue scaffold
AU2024220141A AU2024220141A1 (en) 2017-07-14 2024-09-27 Tissue scaffold

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1711360.6A GB201711360D0 (en) 2017-07-14 2017-07-14 Tissue scaffold

Publications (1)

Publication Number Publication Date
GB201711360D0 true GB201711360D0 (en) 2017-08-30

Family

ID=59713538

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1711360.6A Ceased GB201711360D0 (en) 2017-07-14 2017-07-14 Tissue scaffold

Country Status (8)

Country Link
US (2) US11738112B2 (enExample)
EP (2) EP4338764A3 (enExample)
JP (2) JP2020526337A (enExample)
AU (2) AU2018298970B2 (enExample)
CA (1) CA3068926A1 (enExample)
ES (1) ES2948984T3 (enExample)
GB (1) GB201711360D0 (enExample)
WO (1) WO2019012295A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917398A (zh) * 2019-12-09 2020-03-27 沛嘉医疗科技(苏州)有限公司 生物材料的抗氧化方法及生物材料
GB202004902D0 (en) * 2020-04-02 2020-05-20 Univ Oxford Innovation Ltd Methods and products
US12163957B2 (en) * 2020-06-01 2024-12-10 King Abdullah University Of Science And Technology Methods for detecting his-tagged proteins using NTA probes and polyacrylamide gel electrophoresis
CN114767930B (zh) * 2022-04-11 2023-09-22 山东大学齐鲁医院 一种3d纳米纤维海绵体、制备方法及在脊髓损伤修复领域的应用
JP2025005175A (ja) 2023-06-27 2025-01-16 日亜化学工業株式会社 酸化物蛍光体、及びそれを用いた発光装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598423B1 (fr) * 1985-03-01 1989-03-17 Inst Nat Sante Rech Med Produit a base d'elastine, procede pour sa preparation et ses applications biologiques, en particulier en tant que biomateriaux et supports artificiels
US5989244A (en) * 1994-11-15 1999-11-23 Gregory; Kenton W. Method of use of a sheet of elastin or elastin-based material
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US6638308B2 (en) 1997-10-10 2003-10-28 John D. Corbitt, Jr. Bioabsorbable breast implant
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
EP1403304B1 (en) 2001-05-30 2008-08-27 Keiichi Miyamoto Crosslinked elastin and processes for its production
JP4030881B2 (ja) 2003-01-08 2008-01-09 ペンタックス株式会社 相対回動環状二部材のバヨネット構造
ATE490792T1 (de) 2003-03-31 2010-12-15 Teijin Ltd Geformter elastin-artikel und verfahren zu seiner herstellung
WO2006046626A1 (ja) 2004-10-29 2006-05-04 Kyushu Institute Of Technology 水溶性エラスチンとその製造方法及びそれを含む食品と医薬
US20070104692A1 (en) 2005-11-07 2007-05-10 Quijano Rodolfo C Breast tissue regeneration
DE102006029605A1 (de) 2006-06-26 2007-12-27 Lazar, Harald, Dr. Brustimplantat
ATE529070T1 (de) 2006-07-31 2011-11-15 Organogenesis Inc Mastopexie- und brustrekonstruktionsprothesen
WO2008037028A1 (en) * 2006-09-29 2008-04-03 Martin Kean Chong Ng Tropoelastin-based protoelastin biomaterials
SG174922A1 (en) 2009-03-27 2011-11-28 Ethicon Inc Medical devices with galvanic particulates
WO2010110067A1 (ja) * 2009-03-27 2010-09-30 株式会社マルハニチロ食品 エラスチン及びコラーゲンを用いた架橋物及びその用途
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US20140005784A1 (en) 2012-06-29 2014-01-02 Allergan, Inc. Textured prosthesis with reduced capsular contracture response
US9433489B2 (en) 2013-03-12 2016-09-06 Soft Tissue Regeneration, Inc. Absorbable synthetic braided matrix for breast reconstruction and hernia repair
JP6143163B2 (ja) 2013-03-22 2017-06-07 国立大学法人三重大学 弾性組織様構造体の製造方法
AU2015353653A1 (en) 2014-11-26 2017-06-15 Integra Lifesciences Corporation Process for preparing tissue regeneration matrix
US20180296313A1 (en) 2015-09-23 2018-10-18 Novus Scientific Ab Three-dimensional medical implant for regeneration of soft tissue
IL281898B2 (en) 2018-10-03 2024-09-01 Estab Labs S A Scaffolding for implantable medical devices and methods of use thereof
DK4126088T3 (da) 2020-03-22 2025-10-20 Collplant Ltd Collagenbaserede formuleringer, der kan anvendes som bløde vævsfyldstoffer og/eller implantater

Also Published As

Publication number Publication date
EP4338764A2 (en) 2024-03-20
US20240165299A1 (en) 2024-05-23
JP7693152B2 (ja) 2025-06-17
JP2020526337A (ja) 2020-08-31
AU2018298970B2 (en) 2024-07-04
AU2018298970A1 (en) 2020-01-30
WO2019012295A1 (en) 2019-01-17
ES2948984T3 (es) 2023-09-22
JP2023105244A (ja) 2023-07-28
AU2024220141A1 (en) 2025-01-30
EP3651817A1 (en) 2020-05-20
EP3651817B1 (en) 2023-05-03
US11738112B2 (en) 2023-08-29
EP4338764A3 (en) 2024-06-05
CA3068926A1 (en) 2019-01-17
US20200164104A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
PL3273870T3 (pl) Urządzenia do podwiązywania tkanek
GB201818605D0 (en) Nivel use
GB201519451D0 (en) Implant
SG11201803220UA (en) Time dependent physiologic tissue scaffold
GB201808617D0 (en) Scaffold modification
GB2543540B (en) Decellularising tissue
AU2018298970A1 (en) Tissue scaffold
GB2560369B (en) Tissue engineering scaffolds
GB201805996D0 (en) Tissue scaffold
AU2015330957B2 (en) Bone scaffold improvements
GB201622416D0 (en) Tissue scaffold
GB201515820D0 (en) Tissue engineering
GB2574954B (en) Tissue scaffold and scaffold composition
GB201701438D0 (en) Skine tissue
GB201804366D0 (en) Scaffold
GB201517096D0 (en) Surgical aid
GB201819609D0 (en) Scaffold
PL3727125T3 (pl) Endoskop
ZAA201800573S (en) Spatula
GB201707846D0 (en) Use
GB201608684D0 (en) Scaffold
GB201813461D0 (en) Tissue scaffold
GB201809488D0 (en) Scaffold
GB201809406D0 (en) Scaffold
GB201812895D0 (en) Scaffold

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)